Turner Syndrome
📧 Sign up to get email alerts when something new happens for Turner Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome [Phase 4]
This Phase 4 clinical trial in Turner syndrome is comparing long-term effects of oral versus transdermal estrogen replacement therapy and is…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome [Phase 4]
Phase 4 clinical trial at Aarhus University Hospital is evaluating dose equivalence between oral and transdermal estradiol in women with Tur…
-
FDA label_change · 2024-08-16FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Genotropin (somatropin) from Pfizer, resulting in changes to the labeling. The notice reflects t…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Mehri Turki Webbed Neck Classification
A completed clinical trial evaluating webbed neck classification in Turner syndrome and related conditions such as pterygium colli and Klipp…
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Vosoritide for Short Stature in Turner Syndrome [Phase 2]
Phase 2 clinical trial investigating vosoritide for short stature in Turner syndrome is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: The Danish TURNER Cryopreservation Study [NA]
A clinical trial update from the University of Aarhus describes the TURNER Cryopreservation Study, a study on fertility preservation for ind…
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: A Trial of YPEG-rhGH in Children With Short Stature [Phase 2]
Phase 2 trial update for YPEG-rhGH in children with short stature, including idiopathic short stature and small for gestational age conditio…
-
EMA approval · 2023-07-20EMA Authorised: NutropinAq (somatropin) — Ipsen Pharma
EMA authorised NutropinAq (somatropin) for Turner syndrome and pituitary dwarfism, with Ipsen Pharma as MAH.
-
FDA approval · 2020-03-09FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Norditropin (somatropin) by Novo Nordisk under BLA021148. The action pertains to changes approve…
-
FDA approval · 2020-01-08FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved Genotropin (somatropin) via a supplemental application submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. [Phase 4]
Phase 4 trial update evaluating ease of use, preference, and safety of EutropinPen Inject. in multiple pediatric indications.
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years [Phase 4]
Phase 4 trial evaluating growth hormone to prevent short stature in young girls with Turner syndrome; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-09Clinical Trial Update: Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq [Phase 3]
Phase 3 trial update on IGF-1 monitoring in children treated with NutropinAq, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: A Clinical Study to Assess the Efficacy and Safety of DA-3002 [Phase 3]
Phase 3 trial of DA-3002 for Turner's syndrome has completed; the update does not provide efficacy or safety results.
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN® [Phase 4]
Phase 4 trial assessing predictive markers in children with growth hormone deficiency and Turner syndrome treated with SAIZEN. Results poste…
-
FDA approval · 2018-01-30FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for ZOMACTON (somatropin) by Ferring Pharmaceuticals. The action updates the product's indications o…
-
CLINICAL_TRIALS other · 2017-12-12Clinical Trial Update: A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome [Phase 2]
An update on a Phase 2 clinical trial evaluating PEG-somatropin injections for children with Turner syndrome.
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Estrogen Treatment (Oral vs. Patches) in Turner Syndrome [Phase 3]
A Phase 3 trial comparing oral estrogen to estrogen delivered via skin patches in Turner syndrome has completed.
-
CLINICAL_TRIALS research · 2017-10-12Clinical Trial Update: Observational Prospective Study on Patients Treated With Norditropin®
An observational prospective study assesses outcomes in patients treated with Norditropin (somatropin) for growth hormone-related disorders.
-
CLINICAL_TRIALS research · 2017-10-06Clinical Trial Update: Turner Syndrome: Genotype and Phenotype
This ClinicalTrials.gov entry reports a completed study investigating the genotype and phenotype of Turner syndrome. The study is sponsored …
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Risk of Diabetes in Young Turner Syndrome Patients
A completed study assessed diabetes risk in young patients with Turner syndrome.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome [Phase 2]
This is a Phase 2 clinical trial update evaluating the effects of hormones in growth hormone-treated girls with Turner syndrome.
-
FDA label_change · 2017-05-24FDA Approved: SEROSTIM — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for SEROSTIM (somatropin) from EMD Serono, Inc. to update the product labeling. The changes expand o…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome [NA]
This clinical trial studied whether growth hormone affects early brain development in girls with Turner syndrome. The study has completed an…
-
CLINICAL_TRIALS research · 2017-03-15Clinical Trial Update: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
A completed clinical trial evaluated microRNAs as biomarkers for aortic aneurysm in hereditary aortopathy syndromes such as Marfan syndrome …